Inverness Medical Innovations

Inverness Medical Innovations (IMA) continues to trend higher in response to the company's strong first-quarter results, reported in late April, in which the company swung to a profit from last year.

First-Quarter Results

Sales were up 19% from last year to $443.9 million. Income was up sharply to $771,000, up from a loss of $4.2 million, producing earnings of 56 cents per share, 3 cents ahead of the consensus.

Next-Year Estimate Bullish

Analysts are bullish on the company's long-term prospects, with the next-year estimate pegged at $2.66 per share, a 16% earnings growth projection.

Valuations

Based on the current-year estimate of $2.29, this stock has a P/E multiple of 14X, in line with the overall market.

The Chart

Shares of IMA have been rallying for most of the last 7 months after bottoming out just above $12 in late November. Since then, this stock has topped off above $36, take a look below.

Last Week's Momentum Zacks Rank Buy Stocks

Kongzhong Corp's (KONG) share price is up more than 200% this year on strong quarterly results and bullish earnings projections. Read Full Article.

Andersons Inc. (ANDE) is currently trading at 14X forward earnings with a very impressive 22% earnings growth projection for the next-year period to boot. Read Full Article.

Jefferies Group, Inc. (JEF) pre-released very impressive second-quarter results on June 24 that are far ahead of analyst expectations. Read Full Article.

Healthsouth Corp. (HLS) continues to rally on strong quarterly results and bullish earnings projections. Read Full Article.

Read the full analyst report on ALR